A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of AZD9567.

NCT02760316 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: AZD9567 10 mg
DRUG: AZD9567 20 mg
DRUG: AZD9567 40 mg
DRUG: AZD9567 80 mg
DRUG: Prednisolone 20 mg
DRUG: AZD9567 125 mg
DRUG: AZD9567 155 mg
DRUG: Prednisolone 5 mg
DRUG: Prednisolone 40 mg

Sponsor

AstraZeneca